- Home
- GRDN vs OMCL Comparison
GRDN vs OMCL Comparison
Compare GRDN & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRDN | OMCL |
|---|---|---|
| Founded | 2004 | 1992 |
| Country | United States | United States |
| Employees | 3400 | N/A |
| Industry | Retail-Drug Stores and Proprietary Stores | Computer Manufacturing |
| Sector | Consumer Staples | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.8B |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | GRDN | OMCL |
|---|---|---|
| Price | $34.39 | $33.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | $37.33 | ★ $51.14 |
| AVG Volume (30 Days) | 246.1K | ★ 538.4K |
| Earning Date | 03-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $787,309,000.00 |
| Revenue This Year | $1.13 | $6.77 |
| Revenue Next Year | $9.97 | $5.22 |
| P/E Ratio | ★ $117.77 | $848.50 |
| Revenue Growth | N/A | ★ 9.93 |
| 52 Week Low | $19.17 | $22.66 |
| 52 Week High | $37.43 | $51.84 |
Technical Indicators
Market Signals| Indicator | GRDN | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 57.90 | 28.74 |
| Support Level | $27.73 | $33.25 |
| Resistance Level | $36.13 | $33.87 |
| Average True Range (ATR) | 1.91 | 1.38 |
| MACD | 0.01 | -0.50 |
| Stochastic Oscillator | 67.25 | 1.47 |
Price Performance
Historical ComparisonAbout GRDN Guardian Pharmacy Services Inc.
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.